---
title: "Crescent Biopharma Reports Second Quarter 2025 Financial Results and Recent Business Highlights"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/251003846.md"
description: "Completed Merger with GlycoMimetics and Previously Announced $200 Million Private Financing Supporting Pipeline of Next Generation Therapeutics for Solid Tumors ..."
datetime: "2025-07-31T12:37:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/251003846.md)
  - [en](https://longbridge.com/en/news/251003846.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/251003846.md)
generator: "portal-rs"
---

# Crescent Biopharma Reports Second Quarter 2025 Financial Results and Recent Business Highlights

Completed Merger with GlycoMimetics and Previously Announced $200 Million Private Financing Supporting Pipeline of Next Generation Therapeutics for Solid Tumors ...

### Related Stocks

- [GLYC.US](https://longbridge.com/en/quote/GLYC.US.md)
- [CBIO.US](https://longbridge.com/en/quote/CBIO.US.md)

## Related News & Research

- [Kaiser Aluminum (KALU) Stock Dropped, So What Is Driving Attention Now?](https://longbridge.com/en/news/296564710.md)
- [Insider Unloading: Michael Saks Sells $410K Worth Of RCM Technologies Shares](https://longbridge.com/en/news/296633661.md)
- [Everett Harris & Co. CA Makes New Investment in Procter & Gamble Company (The) $PG](https://longbridge.com/en/news/296451542.md)
- [MDU Resources Group (MDU) Has Investors Looking Closer After Its Latest Update](https://longbridge.com/en/news/296100341.md)
- [Stevanato Group (STVN) Updated Guidance, Is It Still Below Fair Value?](https://longbridge.com/en/news/296070806.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**